Supriya Lifescience Ltd

Supriya Lifescience Ltd

Supriya Lifescience Ltd has received an ESG rating of 'CRISIL ESG 65' in the 'Strong' category from CRISIL ESG Ratings & Analytics Limited.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming compliance for the quarter ended September 30, 2026.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has filed a petition before the Hon'ble Supreme Court of India in connection with a judicial matter, and the company does not wish to comment on the merits or outcome of the proceedings.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the closure of its trading window for insiders and designated persons from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.

Supriya Lifescience Ltd

Supriya Lifescience Ltd held its 18th Annual General Meeting (AGM) on September 24, 2026, through video conferencing. The meeting was attended by the company secretary, independent directors, and other officials. The AGM was conducted in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The scrutinizer's report for the meeting is attached.

Supriya Lifescience Ltd

Supriya Lifescience Ltd held its 18th Annual General Meeting (AGM) on September 24, 2026, through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The meeting commenced at 3.00 p.m. (IST) and concluded at 3.50 p.m. (IST). All resolutions were passed with requisite majority.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has received a court order allowing the provisional release of a consignment of 200 kg of Ketamine Hydrochloride, subject to a deposit of ₹72 lakh. The order also clarifies that adjudication and criminal proceedings may continue in accordance with law.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced an analyst/investor meeting on September 25, 2026, and has uploaded the investor presentation on its website and stock exchanges.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has sent a letter to shareholders whose email ids are not registered with the company, informing them about the Annual Report for the financial year 2025-26 and the 18th Annual General Meeting (AGM) to be held on September 24, 2026.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has informed the stock exchanges that the judicial proceedings against its General Manager – Sales & Marketing are ongoing and awaiting hearing and adjudication. The company will inform the exchanges of any material development.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the dispatch of AGM notice and annual report for FY 2025-26, to be held on September 24, 2026, through video conferencing.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced its Business Responsibility and Sustainability Report for FY 2025-26, along with the Notice of the 18th Annual General Meeting. The report includes details of the company's business activities, products, operations, employees, and sustainability initiatives.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the 18th Annual General Meeting (AGM) to be held on September 24, 2026, through Video Conferencing (VC) or other audio visual means (OAVM). The AGM will consider and approve the audited financial statements for FY 2025-26, declare a final dividend of Re. 1.00/- (50%) per equity share, and ratify the remuneration of the cost auditors for FY 2026-27.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has submitted its Annual Report for the financial year 2025-26, including the Business Responsibility and Sustainability Report, along with the Notice of AGM, which are being sent through electronic mode to the Members of the Company.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the 18th Annual General Meeting (AGM) to be held on September 24, 2026, through Video Conferencing (VC)/Other Audio Visual Means (OAVM). The company has also announced a one-time Specimen Window for the redemption of shareholder deeds or Physical Shares that were lodged prior to April 1, 2019.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the record date for determining members eligible to receive dividend for FY 2025-26. The company has recommended a final dividend of Re. 1.00/- per equity share of Rs. 2/- each, subject to approval of members at the Annual General Meeting scheduled to be held on September 24, 2026. The dividend will be paid within 30 days to the members whose names appear in the Register of Members of the Company and/or Register of Beneficial Owners maintained by the Depositories as on the record date.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the voting results of its postal ballot, where the re-appointment of Mr. Balasaheb Sawant as Whole Time Director and Key Managerial Personnel for a term of three consecutive years was passed with a requisite majority. The voting results show that all shareholders, including promoters and public institutions, voted in favor of the resolution.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the voting results of its postal ballot, where the re-appointment of Mr. Balasaheb Sawant as Whole Time Director and Key Managerial Personnel for a term of three consecutive years has been passed with the requisite majority.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the availability of the earnings call transcript for Q1 FY '27, with revenue at Rs. 190 crores, a 31% year-on-year growth, and EBITDA at Rs. 47 crores, a decline of 8.1% year-on-year.

Supriya Lifescience Ltd

Supriya Lifescience Ltd has announced the availability of the audio recording of its earnings call held on August 14, 2026, discussing the company's operational and financial performance for the quarter ended June 30, 2026. The recording is available on the company's website.